Peripheral Blood Stem Cell TransplantationTransplantation, AutologousHematopoietic Stem Cell TransplantationHematopoietic Stem Cell MobilizationTransplantation ConditioningTransplantation, HomologousMelphalanGranulocyte Colony-Stimulating FactorLeukapheresisCombined Modality TherapyHematologic NeoplasmsAntigens, CD34Blood Component RemovalStem Cell TransplantationCyclophosphamideMultiple MyelomaAntineoplastic Combined Chemotherapy ProtocolsMyeloablative AgonistsBusulfanGraft vs Host DiseaseTreatment OutcomeLymphoma, Non-HodgkinGraft SurvivalBone Marrow TransplantationEtoposideHematopoietic Stem CellsThiotepaAntineoplastic Agents, AlkylatingRemission InductionRecurrenceCytophagocytosisCarmustineIfosfamideSalvage TherapyVincristineAmyloidosisStem CellsCytarabineHematopoiesisDisease-Free SurvivalHodgkin DiseaseCord Blood Stem Cell TransplantationRetrospective StudiesNeoplasmsTransplantation ChimeraSurvival RateTissue DonorsWhole-Body IrradiationSurvival AnalysisTime FactorsLymphoma, T-CellInfectionDoxorubicinHistocompatibilityPOEMS SyndromePlatelet CountCarboplatinPrednisoneHistocompatibility TestingImmunosuppressive AgentsTransplantation, IsogeneicLeukemia, Myeloid, AcuteDexamethasoneVidarabineFollow-Up StudiesRecombinant ProteinsBlood Cell CountLeukemiaAntineoplastic AgentsLymphomaBone Marrow PurgingFatal OutcomeProspective StudiesCytomegalovirus InfectionsBlood CellsGraft vs Leukemia EffectFeasibility StudiesImmunophenotypingMyelodysplastic SyndromesAnemia, AplasticBlood Transfusion, AutologousLiver TransplantationLeukemia, Myelogenous, Chronic, BCR-ABL PositiveLymphocyte DepletionT-LymphocytesPrognosisLeukocytes, MononuclearGranulosa Cell TumorHematologic DiseasesHistiocytosis, Non-Langerhans-CellLivedo ReticularisBreast NeoplasmsOpportunistic InfectionsBone MarrowHLA AntigensPrecursor Cell Lymphoblastic Leukemia-LymphomaNeoplasms, Germ Cell and EmbryonalGiant Cell Tumor of BoneCyclosporineBlood Donors